The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
© 2017 Elsevier Masson SAS Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD) worldwide. The early effective treatment of high plasma glucose could delay or prevent the onset of DN. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are new target treatments for ameliora...
Saved in:
Main Authors: | Krit Jaikumkao, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Siriporn C. Chattipakorn, Nipon Chattipakorn, Anusorn Lungkaphin |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85026376186&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/57858 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
by: Krit Jaikumkao, et al.
Published: (2018) -
The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
by: Jaikumkao K., et al.
Published: (2017) -
Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model
by: Krit Jaikumkao, et al.
Published: (2018) -
Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model
by: Krit Jaikumkao, et al.
Published: (2018) -
Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model
by: Krit Jaikumkao, et al.
Published: (2019)